분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2013-04-26 11:03:20 , Hit : 1971
 DNA: Celebrate the unknowns

Philip Ball1
Journal name:
Nature
Volume:
496,
Pages:
419–420
Date published:
(25 April 2013)
DOI:
doi:10.1038/496419a
Published online 24 April 2013
Article tools
PDF
DNA: Celebrate the unknowns


On the 60th anniversary of the double helix, we should admit that we don't fully understand how evolution works at the molecular level, suggests Philip Ball.


Subject terms:

This week's diamond jubilee of the discovery of DNA's molecular structure rightly celebrates how Francis Crick, James Watson and their collaborators launched the 'genomic age' by revealing how hereditary information is encoded in the double helix. Yet the conventional narrative — in which their 1953 Nature paper led inexorably to the Human Genome Project and the dawn of personalized medicine — is as misleading as the popular narrative of gene function itself, in which the DNA sequence is translated into proteins and ultimately into an organism's observable characteristics, or phenotype.

Sixty years on, the very definition of 'gene' is hotly debated. We do not know what most of our DNA does, nor how, or to what extent it governs traits. In other words, we do not fully understand how evolution works at the molecular level.


That sounds to me like an extraordinarily exciting state of affairs, comparable perhaps to the disruptive discovery in cosmology in 1998 that the expansion of the Universe is accelerating rather than decelerating, as astronomers had believed since the late 1920s. Yet, while specialists debate what the latest findings mean, the rhetoric of popular discussions of DNA, genomics and evolution remains largely unchanged, and the public continues to be fed assurances that DNA is as solipsistic a blueprint as ever.

The more complex picture now emerging raises difficult questions that this outsider knows he can barely discern. But I can tell that the usual tidy tale of how 'DNA makes RNA makes protein' is sanitized to the point of distortion. Instead of occasional, muted confessions from genomics boosters and popularizers of evolution that the story has turned out to be a little more complex, there should be a bolder admission — indeed a celebration — of the known unknowns.

DNA dispute
A student referring to textbook discussions of genetics and evolution could be forgiven for thinking that the 'central dogma' devised by Crick and others in the 1960s — in which information flows in a linear, traceable fashion from DNA sequence to messenger RNA to protein, to manifest finally as phenotype — remains the solid foundation of the genomic revolution. In fact, it is beginning to look more like a casualty of it.

Although it remains beyond serious doubt that Darwinian natural selection drives much, perhaps most, evolutionary change, it is often unclear at which phenotypic level selection operates, and particularly how it plays out at the molecular level.

Take the Encyclopedia of DNA Elements (ENCODE) project, a public research consortium launched by the US National Human Genome Research Institute in Bethesda, Maryland. Starting in 2003, ENCODE researchers set out to map which parts of human chromosomes are transcribed, how transcription is regulated and how the process is affected by the way the DNA is packaged in the cell nucleus. Last year, the group revealed1 that there is much more to genome function than is encompassed in the roughly 1% of our DNA that contains some 20,000 protein-coding genes — challenging the old idea that much of the genome is junk. At least 80% of the genome is transcribed into RNA.

Some geneticists and evolutionary biologists say that all this extra transcription may simply be noise, irrelevant to function and evolution2. But, drawing on the fact that regulatory roles have been pinned to some of the non-coding RNA transcripts discovered in pilot projects, the ENCODE team argues that at least some of this transcription could provide a reservoir of molecules with regulatory functions — in other words, a pool of potentially 'useful' variation. ENCODE researchers even propose, to the consternation of some, that the transcript should be considered the basic unit of inheritance, with 'gene' denoting not a piece of DNA but a higher-order concept pertaining to all the transcripts that contribute to a given phenotypic trait3.

According to evolutionary biologist Patrick Phillips at the University of Oregon in Eugene, projects such as ENCODE are showing scientists that they don't really understand how genotypes map to phenotypes, or how exactly evolutionary forces shape any given genome.

Complex code
The ENCODE findings join several other discoveries in unsettling old assumptions. For example, epigenetic molecular alterations to DNA, such as the addition of a methyl group, can affect the activity of genes without altering their nucleotide sequences. Many of these regulatory chemical markers are inherited, including some that govern susceptibility to diabetes and cardiovascular disease4. Genes can also be regulated by the spatial organization of the chromosomes, in turn affected by epigenetic markers. Although such effects have long been known, their prevalence may be much greater than previously thought5.

Another source of ambiguity in the genotype–phenotype relationship comes from the way in which many genes operate in complex networks. For example, many differently structured gene networks might result in the same trait or phenotype6. Also, new phenotypes that are viable and potentially superior may be more likely to emerge through tweaks to regulatory networks than through more risky alterations to protein-coding sequences7. In a sense this is still natural selection pulling out the best from a bunch of random mutations, but not at the level of the DNA sequence itself.

One consequence of this complex genotype–phenotype relationship is that it may impose constraints on natural selection. If the same phenotypes can result from many similarly structured gene networks, it might take a long time for a 'fitter' phenotype to arise8. Alternatively, mutations may accumulate, free from selective 'weeding', thanks to the robustness of networks in maintaining a particular phenotype. Such hidden variation might be unmasked by some new environmental stress, enabling fresh adaptations to emerge9. These sorts of constraints and opportunities are poorly understood; evolutionary theory does not help biologists to predict what kinds of genetic network they should expect to see in any one context.

Researchers are also still not agreed on whether natural selection is the dominant driver of genetic change at the molecular level. Evolutionary geneticist Michael Lynch of Indiana University Bloomington has shown through modelling that random genetic drift can play a major part in the evolution of genomic features, for example the scattering of non-coding sections, called introns, through protein-coding sequences. He has also shown that rather than enhancing fitness, natural selection can generate a redundant accumulation of molecular 'defences', such as systems that detect folding problems in proteins10. At best, this is burdensome. At worst, it can be catastrophic.

In short, the current picture of how and where evolution operates, and how this shapes genomes, is something of a mess. That should not be a criticism, but rather a vote of confidence in the healthy, dynamic state of molecular and evolutionary biology.

A problem shared
Barely a whisper of this vibrant debate reaches the public. Take evolutionary biologist Richard Dawkins' description in Prospect magazine last year of the gene as a replicator with “its own unique status as a unit of Darwinian selection”. It conjures up the decades-old picture of a little, autonomous stretch of DNA intent on getting itself copied, with no hint that selection operates at all levels of the biological hierarchy, including at the supraorganismal level2, or that the very idea of 'gene' has become problematic.

Why this apparent reluctance to acknowledge the complexity? One roadblock may be sentimentality. Biology is so complicated that it may be deeply painful for some to relinquish the promise of an elegant core mechanism. In cosmology, a single, shattering fact (the Universe's accelerating expansion) cleanly rewrote the narrative. But in molecular evolution, old arguments, for instance about the importance of natural selection and random drift in driving genetic change, are now colliding with questions about non-coding RNA, epigenetics and genomic network theory. It is not yet clear which new story to tell.

Then there is the discomfort of all this uncertainty following the rhetoric surrounding the Human Genome Project, which seemed to promise, among other things, 'the instructions to make a human'. It is one thing to revise our ideas about the cosmos, another to admit that we are not as close to understanding ourselves as we thought.

“Simplistic portrayals of evolution encourage equally simplistic demolitions.”
There may also be anxiety that admitting any uncertainty about the mechanisms of evolution will be exploited by those who seek to undermine it. Certainly, popular accounts of epigenetics and the ENCODE results have been much more coy about the evolutionary implications than the developmental ones. But we are grown-up enough to be told about the doubts, debates and discussions that are leaving the putative 'age of the genome' with more questions than answers. Tidying up the story bowdlerizes the science and creates straw men for its detractors. Simplistic portrayals of evolution encourage equally simplistic demolitions.

When the structure of DNA was first deduced, it seemed to supply the final part of a beautiful puzzle, the solution for which began with Charles Darwin and Gregor Mendel. The simplicity of that picture has proved too alluring. For the jubilee, we should do DNA a favour and lift some of the awesome responsibility for life's complexity from its shoulders.

ReferencesReferences• Author information•

The ENCODE Project Consortium Nature 489, 57–74 (2012).
CAS PubMed Article Show contextDoolittle, W. F. Proc. Natl Acad. Sci. USA 110, 5294–5300 (2013).
CAS PubMed Article Show contextDjebali, S. et al. Nature 489, 101–108 (2012).
CAS PubMed Article Show contextJablonka, E. & Raz, G. Q. Rev. Biol. 84, 131–176 (2009).
ISI PubMed Article Show contextMattick, J. S. Proc. Natl Acad. Sci. USA 109, 16400–16401 (2012).
PubMed Article Show contextWagner, A. Trends Genet. 27, 397–410 (2011).
CAS PubMed Article Show contextMattick, J. S. FEBS Lett. 585, 1600–1616 (2011).
CAS PubMed Article Show contextWagner, A. Trends Ecol. Evol. 26, 577–584 (2011).
PubMed Article Show contextJarosz, D. F. & Lindquist, S. Science 330, 1820–1824 (2010).
CAS ISI PubMed Article Show contextLynch, M. Proc. Natl Acad. Sci. USA 109, 18851–18856 (2012).
PubMed Article Show contextDownload references

Philip Ball is a freelance science writer based in London.
Corresponding author
Correspondence to:
Philip Ball
Author details
Philip Ball
Contact Philip Ball

Search for this author in:
NPG journalsPubMedGoogle Scholar
Related links







727   임자 있는 초원들쥐가 외간들쥐를 거들떠보지도 않는 이유: 후성유전학  이성욱 2013/06/05 3279
726   면역시스템이 유익세균과 평화로운 공존을 유지하는 방법  이성욱 2013/05/28 2492
725   TNF를 이용한 안전한 항종양 치료법  이성욱 2013/05/28 2656
724   Viruses in the gut protect from infection  이성욱 2013/05/22 2907
723   황우석을 넘어서: 미국의 과학자들, 체세포복제 기술로 인간 배아줄기세포 제조 성공  이성욱 2013/05/17 2462
722   Janssen's experimental drug for hepatitis C gets FDA fast track  이성욱 2013/05/15 2827
721   세상을 바꿀 10가지 기술  이성욱 2013/05/13 2330
720   Most Europeans share recent ancestors  이성욱 2013/05/10 2156
719   약물 저항성 세균을 파괴하는 방법  이성욱 2013/05/10 2552
718   분자생물학의 거성(巨星) 떨어지다; 프랑수아 자콥의 삶과 업적  이성욱 2013/05/09 2833
717   FDA fast tracks AbbVie hepatitis C drug  이성욱 2013/05/08 2196
716   Targeted drugs to tackle hepatitis C  이성욱 2013/05/06 1798
  DNA: Celebrate the unknowns  이성욱 2013/04/26 1971
714   Hepatitis C drug nears approval  이성욱 2013/04/24 2121
713   텔로머레이즈를 표적으로 삼는 새로운 항암 요법  이성욱 2013/04/24 3107
712   A pathogenic picornavirus acquires an envelope by hijacking cellular membranes  이성욱 2013/04/23 3003
711   BMS, Santaris Make Potentially $100M+ mRNA-Targeting Deal  이성욱 2013/04/17 2148
710   Scientists Map Elusive 3-D Structure of Telomerase Enzyme, Key Actor in Cancer, Aging  이성욱 2013/04/17 2305
709   Gilead seeks FDA OK for game-changing hepatitis C drug  이성욱 2013/04/10 2114
708   'RNA sponge' mechanism may cause ALS/FTD neurodegeneration  이성욱 2013/04/02 2605

[이전 10개] [1]..[21][22][23][24][25][26][27] 28 [29][30]..[64] [다음 10개]
 

Copyright 1999-2021 Zeroboard / skin by ROBIN